ResMed Inc. Q4 2025 Earnings and Dividend Announcement

SEC Filing 8-K (0001193125-25-170512)

ResMed Inc. reported its financial results for the fourth quarter and fiscal year ended June 30, 2025. The company achieved a 10% year-over-year revenue growth, reaching $1.3 billion for the quarter and $5.1 billion for the full year. Operating profit increased by 19% for the quarter, with non-GAAP operating profit also up by 19%. The company declared a quarterly cash dividend of $0.60 per share, payable on September 18, 2025, to shareholders of record as of August 14, 2025. ResMed's strong performance was driven by robust global demand for its sleep and breathing health devices, as well as its expanding digital health ecosystem. The company also announced the acquisition of VirtuOx, a leading independent diagnostic testing facility, to enhance its diagnostic services.